- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–7 [CrossRef] [PubMed] [Google Scholar]
- Hacke W, Kaste M, Bluhmki E, et al (2008) Thrombolysis with alteplase 3 to 4,5 hours after acute ischaemic stroke. N Engl J Med 359:1317–29 [CrossRef] [PubMed] [Google Scholar]
- Rodrigues FB, Neves JB, Caldeira D, et al (2016) Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ 353:i1754 [CrossRef] [Google Scholar]
- Sylaja PN, Cote R, Buchan AM, Hill MD (2006) Thrombolysis in patients older than 80 years with acute ischemic stroke: Canadian Altéplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 77:826–9 [CrossRef] [PubMed] [Google Scholar]
- De keyser J, Gdovinova Z, Uyttenboogaart M, et al (2007) Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 38:2612–8 [CrossRef] [PubMed] [Google Scholar]
- The NINDS rt-PA Stroke Study Group (1997) A systems approach to immediate evaluation and management of hyperacute stroke: experience at eight centers and implications for community practice and patient care. Stroke 28:1530–40 [CrossRef] [PubMed] [Google Scholar]
- Chiu D, Krieger D, Villar-Cordova C, et al (1998) Intravenous tissue plasminogen activator for ischemic stroke : Feasibility, safety and efficacy in the first year of clinical practice. Stroke 29:18–22 [CrossRef] [PubMed] [Google Scholar]
- Chapman KM, Woolfenden AR, Graeb D, et al (2000) Intravenous tissue plasminogen activator for acute ischemic stroke: A Canadian hospital's experience. Stroke 31:2920–4 [CrossRef] [PubMed] [Google Scholar]
- Wiegand N, Lüthy R, Vogel B, et al (2004) Intravenous thrombolysis for ischaemic stroke is also safe and efficient without a specialised neuro-intensive care unit. Swiss Med Wkly 134:14–7 [PubMed] [Google Scholar]
- Hacke W, Kaste M, Fieschi C, et al (1998) Randomised double-blind controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245–51 [CrossRef] [PubMed] [Google Scholar]
- Wahlgren N, Ahmed N, Davalos A, et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke MOnitoring STudy (SITS-MOST): an observational study. Lancet 369:275–82 [CrossRef] [PubMed] [Google Scholar]
- Albers GW, Thijs VN, Wechsler L, et al (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 60:508–17 [CrossRef] [PubMed] [Google Scholar]
- Lansberg MG, Albers GW, Wijman CA (2007) Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: A review of the risk factors. Cerebrovasc Dis 24:1–10 [CrossRef] [Google Scholar]
- Hacke W, Donnan G, Fieschi C, ALANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768–74 [CrossRef] [PubMed] [Google Scholar]
Accès gratuit
| Numéro |
Ann. Fr. Med. Urgence
Volume 7, Numéro 4, Juillet 2017
|
|
|---|---|---|
| Page(s) | 228 - 233 | |
| Section | Article original / Original article | |
| DOI | https://doi.org/10.1007/s13341-017-0763-z | |
| Publié en ligne | 7 juillet 2017 | |
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.